Parkinson disease
Serina Therapeutics merges with struggling AgeX Therapeutics to go public and advance its Parkinson’s drug
Anika Sharma
AgeX Therapeutics, a biotech that has been facing financial difficulties and stalled preclinical programs for years, has finally found a ...
